Moss, R. A., Moore, D., Mulchahy, M. F., Nahum, K., Li, H., Moore, K., . . . Poplin, E. (2010). Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer. International Society of Gastrointestinal Oncology.
Styl cytowania ChicagoMoss, Rebecca A., et al. Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer. International Society of Gastrointestinal Oncology, 2010.
Styl cytowania MLAMoss, Rebecca A., et al. Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer. International Society of Gastrointestinal Oncology, 2010.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..